
Sign up to save your podcasts
Or
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
4.3
690690 ratings
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
1,634 Listeners
4,326 Listeners
1,744 Listeners
8,642 Listeners
3,452 Listeners
111,044 Listeners
55,842 Listeners
2,239 Listeners
5,412 Listeners
5,916 Listeners
2,944 Listeners
2,021 Listeners
15,326 Listeners
4,368 Listeners
154 Listeners
1,145 Listeners
389 Listeners